You are here

Amarin

The Most Promising Biotech Names Heading Into 2019

Investopedia

Mon, 12/31/18 - 12:18 pm

TG Therapeutics

2 Biotech Stocks Poised for Big Gains in 2019

Motley Fool

Mon, 12/3/18 - 10:42 pm

Amarin raises $200M ahead of Vascepa push

BioCentury

Tue, 11/27/18 - 11:48 pm

Amarin's Vascepa trial stirs data debate as stock drops 10%

Biopharma Dive

Mon, 11/12/18 - 11:42 pm

Amarin's Fish-Oil-Derived Drug Shows Great Promise — With Big Caveats

Forbes

Sun, 11/11/18 - 09:19 pm

Why Amarin Stock Jumped 28% in October -- and Why a Bigger Move Could Come Soon

Motley Fool

Sun, 11/4/18 - 02:33 pm

Experts question Amarin's early touting of Vescepa data ahead of detailed results

Endpoints

Fri, 11/2/18 - 11:12 am

[video+transcript] How Big Could Amarin's Vascepa Be?

Motley Fool

Mon, 10/1/18 - 09:54 am

3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph

Yahoo/Motley Fool

Thu, 09/27/18 - 10:07 am

Amarin Soars as Fish Oil Pill Cuts Risk of Strokes in Long-Awaited Study

Xconomy

Mon, 09/24/18 - 09:37 am

Why Amarin Corporation Skyrocketed 23.9% in August

Motley Fool

Tue, 09/4/18 - 09:41 am

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

Yahoo/Benzinga

Mon, 09/3/18 - 01:09 pm

Sangamo BioSciences

ProQR Therapeutics

Atossa Genetics

Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week

Motley Fool

Mon, 09/3/18 - 12:20 pm

CRISPR Therapeutics

Vertex Pharmaceuticals

Analysts: Amarin poised for huge gains if Vascepa trial comes back positive

Medical Marketing and Media

Mon, 08/6/18 - 11:58 pm

Amarin's Vascepa goes on TV to lay groundwork for impending CV outcomes data

Fierce Pharma

Mon, 07/30/18 - 11:32 pm

Sink or swim for fish oils, and Amarin

EP Vantage

Mon, 07/16/18 - 09:58 am

Boom-or-Bust News Is On Tap Soon for Amarin

Motley Fool

Thu, 04/5/18 - 08:54 am

Amarin's Salyer preps for Vascepa push

Medical Marketing and Media

Tue, 12/12/17 - 10:55 pm

8 Major FDA Decisions and Trial Results to Watch for in September

24/7 Wall St

Sat, 09/3/16 - 12:17 pm

Array Biopharma

Mast Therapeutics

Threshold Pharmaceuticals

Amarin slips after adding second interim efficacy trial to PhIII CV trial

Fierce Biotech

Thu, 08/4/16 - 09:13 pm

clinical trials

Pages